Embolic protection device

Abstract
An embolic protection device includes a catheter body having a central longitudinal lumen, a guidewire positioned within the central longitudinal lumen, and a graft member that is generally tubular in shape in an undeployed state and generally frustroconical in shape in a deployed state. A plurality of openings are formed in the graft member and a plurality of arm members interconnect a proximal end of the graft member with the catheter body. A distal end of the graft member is connected to the guidewire or the atraumatic tip. The graft member may be fabricated of superelastic materials, plastically deformable materials or self-expanding materials and the plurality of openings are capable of diametric expansion and reduction proportionate to the degree of diametric expansion and reduction of a corresponding transverse cross-sectional region of the graft member when in the deployed state to capture emboli or particulate matter and minimize extrusion of the captured material through the openings in the graft member when the graft member is collapsed.
Description




BACKGROUND OF THE INVENTION




The present invention relates generally to embolic protection devices. More specifically, the present invention pertains to catheter-based devices for trapping emboli, tissue, arterioschlerotic plaque or other particulate matter in the bloodstream. During angioplasty and stent implantation procedures, oftentimes emboli or other particulate matter is dislodged from the vascular wall. Once dislodged, this particulate matter enters the bloodflow and, unless trapped, collected and removed from the body in some fashion, poses a serious risk to the patient.




Conventional embolic protection devices typically employ umbrella-like baskets in which structural support members are fabricated of elastically strained segments, such as stainless steel or nitinol wire or hypotubing, and rely upon the relative antegrade and retrograde movement of coaxial shafts of a catheter member to deploy and collapse the embolic basket in a manner similar to the way an umbrella is opened and closed. One disadvantage of these umbrella-like devices is increased profile because the material forming the embolic basket must be folded in some manner when the basket is not deployed. Another disadvantage of umbrella-like devices is the excess flap material comprising the embolic basket when under-deployed will fold and invaginate into the lumen of the vessel causing poor apposition between the vessel wall and embolic basket.




Moreover, conventional embolic protection devices are typically fashioned of materials having a relatively constant open surface area across the surface area of the embolic basket. The structure of the embolic basket in conventional embolic protection devices is such that the open spaces are dimensioned to capture emboli or other particulate matter of a certain size that are dislodged as a result, for example, of the angioplasty or stent implantation procedure. With conventional embolic protection devices, the design of the device anticipates that a certain fraction of emboli or particulate matter will pass through the device and into the patient's general circulation.




BRIEF SUMMARY OF THE INVENTION




In accordance with one aspect of the invention, an embolic protection device comprising a first elongate member having a lumen, a second elongate member extending through the lumen and being movable with respect to the first elongate member, a graft member having a proximal end portion connected to the first elongate member and a distal end portion connected to the second elongate member, and a plurality of openings extending through the graft member along a length thereof is provided. The graft member is expandable from an undeployed generally tubular state to a deployed generally frustroconical state upon relative movement between the first and second elongate members in a first direction. The openings generally decrease in size from the proximal end toward the distal end when the graft member is in the deployed state to thereby capture and retain emboli and other particulate matter of different sizes.




In accordance with a further aspect of the invention, an embolic protection device comprises a catheter body having a central longitudinal lumen, a guidewire having an atraumatic tip positioned at a distal end thereof, and a graft member movable between an undeployed state and a deployed state. The guidewire is coaxially positioned within the central longitudinal lumen of the catheter body. The graft member is preferably of a generally tubular shape in the undeployed state and of a generally frustroconical shape in the deployed state. The graft member has a plurality of openings that extend along a length thereof. A plurality of arm members interconnect a proximal end of the graft member and the catheter body. A distal end of the graft member is connected to one of the guidewire and the atraumatic tip. The graft member is movable between the undeployed and deployed states upon relative movement between the catheter body and the guide wire. Preferably, the graft member is constructed of a material such that each opening expands or reduces in size in proportion to an amount of radial expansion or reduction, respectively, of a corresponding transverse cross sectional region of the graft member with which the opening is associated, to thereby capture emboli and other particulate matter when the graft member is in the deployed state and minimize extrusion of the captured material through the openings in the graft member when the graft member is in the undeployed state.











BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS




The foregoing summary, as well as the following detailed description of preferred embodiments of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there is shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown. In the drawings:





FIG. 1

is a perspective view of a first embodiment of the inventive embolic protection device;





FIG. 2

is a perspective view of the first embodiment of the inventive embolic protection device in its deployed state;





FIG. 3A

is a diagrammatic perspective view of a graft portion of the inventive embolic protection device in its collapsed or undeployed state;





FIG. 3B

is a diagrammatic perspective view of the graft portion in its expanded or deployed state;





FIG. 4

is a perspective view of the first embodiment of the inventive embolic protection device in its collapsed or undeployed state with captured emboli;





FIG. 5

is a perspective view of a second embodiment of the inventive embolic protection device in its collapsed or undeployed state;





FIG. 6

is a perspective view of the second embodiment of the inventive embolic protection device in its expanded or deployed state;





FIG. 7

is a cross-sectional view taken along line


7





7


of

FIG. 5

;





FIG. 8

is a cross-sectional view taken along line


8





8


of

FIG. 6

;





FIG. 9A

is a side elevational view of a third embodiment of the inventive embolic protection device in its collapsed or undeployed state; and





FIG. 9B

is a side elevational view of the third embodiment of the inventive embolic protection device in its expanded or deployed state.





FIG. 10A

is a side elevational view of a fourth embodiment of the inventive embolic protection device in its collapsed or undeployed state.





FIG. 10B

is a side elevational view of the fourth embodiment of the inventive embolic protection device in its expanded or deployed state.











It is noted that the drawings are intended to represent only typical embodiments of the invention and therefore should not be construed as limiting the scope thereof. The invention will now be described in greater detail with reference to the drawings, wherein like parts throughout the drawing figures are represented by like numerals.




DETAILED DESCRIPTION OF THE INVENTION




Turning now to the drawings, and with particular reference to

FIGS. 1-4

, an embolic protection device (EPD)


10


in accordance with the present invention is illustrated. The EPD


10


is especially applicable as an in-dwelling device or for use in conjunction with an interventional device, such as a PTCA balloon catheter, for capturing emboli and/or other particulate matter within the bloodstream of a patient. The EPD


10


serves at least the dual purpose of: 1) functioning as a standard guide wire thereby allowing a catheter-borne medical device, such as a balloon dilation catheter of the type typically used for angioplasty and balloon expandable stent deployment, to be delivered to a site within a body cavity; and


2


) removing particulate matter from the bloodstream that may be associated with the interventional procedure that requires use of the guide wire.




The EPD


10


preferably comprises a guidewire


12


terminated at a distal end thereof with an atraumatic tip


13


, a tubular catheter body


14


coaxially and concentrically positioned about the guidewire


12


and reciprocally moveable thereupon, and a graft member or embolic basket


16


coaxially and concentrically positioned about the tubular catheter body


14


and the guidewire


12


. The guidewire


12


may be tubular or solid along its entire length or may transition between solid and tubular along its length. A distal end


21


of the graft member


16


is coupled to the guidewire


12


proximal to the atraumatic tip


13


and distal to the catheter body


14


. A proximal end


20


of the graft member


16


is coupled to the tubular catheter body


14


by a plurality of articulating arm members


18


. The articulating arm members


18


may be constructed of braided wire.




In accordance with a preferred embodiment of the invention, the graft member


16


is fabricated of a metal, pseudometallic or polymeric film and formed either as a tubular member or as a planar member then rolled into a tubular shape. Each of the plurality of articulating arm members


18


are coupled at a first end


22


thereof to the proximal end


20


of the graft member


16


and at a second end


24


thereof to a distal region of the tubular catheter body


14


.




The graft member


16


has a plurality of openings


30


that pass through a wall of the graft member


16


and communicate between an abluminal wall surface and a luminal wall surface of the graft member


16


to thereby form a porous thin-walled polymer or metallic tube. The plurality of openings


30


permit passage of body fluid, such as blood, through the graft member


16


, but exclude the passage of emboli and other particulate matter when the graft member


16


is diametrically enlarged.




In accordance with a preferred embodiment of the invention, the plurality of openings


30


generally comprise a plurality of longitudinal slots formed in the graft member


16


which enlarge and open when the graft member


16


is expanded to its enlarged diameter. While it is expressly contemplated that the openings


30


may be formed as longitudinal slots in the graft member


16


, those skilled in the art will appreciate that other opening geometries, such as circles, ovals, ellipses, squares, diamonds, star-shapes, polygons or the like may also be employed. Additionally, not only the geometry of the plurality of openings


30


, but the sizes of the openings may be varied. By varying the size of the openings along the longitudinal axis of the graft member


16


, it is possible to achieve greater control over the relative porosity of the graft member


16


along its longitudinal axis when in the expanded state in order to capture emboli and other particulate matter in the blood stream.




The particular material used to form the graft member


16


is chosen for its biocompatibility, mechanical properties, i.e., tensile strength, yield strength, and, in the case where vapor deposition is employed to fabricate the graft member


16


, its ease of deposition. By way of example, the graft member


16


can be constructed of a porous thin-walled polymer or metallic tube that is capable of being elastically or superelastically expanded diametrically such as to take on a generally frustroconical shape in its deployed state under the influence of a positive pressure such as that imparted by the plurality of articulating arm members.




For purposes of this application, the terms “pseudometal” and “pseudometallic” are intended to mean a biocompatible material which exhibits biological response and material characteristics substantially the same as biocompatible metals. Examples of pseudometallic materials include, for example, composite materials and ceramics. Composite materials are composed of a matrix material reinforced with any of a variety of fibers made from ceramics, metals, or polymers. The reinforcing fibers are the primary load carriers of the material, with the matrix component transferring the load from fiber to fiber. Reinforcement of the matrix material may be achieved in a variety of ways. Fibers may be either continuous or discontinuous. Reinforcement may also be in the form of particles. Examples of composite materials include those made of carbon fibers, boron fibers, boron carbide fibers, carbon and graphite fibers, silicon carbide fibers, steel fibers, tungsten fibers, graphite/copper fibers, titanium and silicon carbide/titanium fibers.




The graft member


16


may be fabricated of pre-existing conventional wrought materials, such as stainless steel or nitinol hypotubes, or may be fabricated by thin film techniques. In addition to wrought materials that are made of a single metal or metal alloy, the inventive grafts may comprise a monolayer of biocompatible material or of a plurality of layers of biocompatible materials. Laminate structures are generally known to increase the mechanical strength of sheet materials, such as wood or paper products. Laminates are used in the field of thin film fabrication also to increase the mechanical properties of the thin film, specifically hardness and toughness. Laminate metal foils have not been used or developed because the standard metal forming technologies, such as rolling and extrusion, for example, do not readily lend themselves to producing laminate structures. Vacuum deposition technologies can be developed to yield laminate metal structures with improved mechanical properties. In addition, laminate structures can be designed to provide special qualities by including layers that have special properties such as superelasticity, shape memory, radio-opacity, corrosion resistance etc.




The metals contemplated include, without limitation, the following: titanium, vanadium, aluminum, nickel, tantalum, zirconium, chromium, silver, gold, silicon, magnesium, niobium, scandium, platinum, cobalt, palladium, manganese, molybdenum and alloys thereof, such as zirconium-titanium-tantalum alloys, nitinol, and stainless steel. Additionally, in the case where multiple layers and/or laminates of films are employed, each layer of material used to form the graft may be doped with another material for improving properties of the material, such as radio-opacity or radioactivity, for example by doping with tantalum, gold, or radioactive isotopes.




When the EPD


10


is in its undeployed or collapsed state, as depicted in

FIG. 1

, each of the plurality of articulating arm members


18


is positioned parallel to a longitudinal axis of the EPD


10


. When relative movement between the guidewire


12


and the catheter body member


14


occurs, such as by antegrade movement of the guidewire


12


or retrograde movement of the catheter body member


14


, each of the articulating arm members


18


are urged from their longitudinal orientation into a generally radial orientation relative to the longitudinal axis of the EPD


10


.




As each of the articulating arm members


18


undergo their orientational change, a positive pressure is exerted by the plurality of articulating arm members


18


to the proximal end


20


of the graft member


16


, which then undergoes a geometric change and diametrically enlarges from its undeployed diameter D


1


to its enlarged deployed diameter D


2


, as depicted in

FIGS. 3A and 3B

. The diametric change of the graft member


16


from D


1


to D


2


is preferably an elastic or superelastic deformation in which D


1


is associated with the low strain configuration of the graft member


16


. However, in the case where D


2


is associated with the low strain configuration, release of a constraining force exerted by arms


18


can permit self-expansion of the graft member


16


. The diametric change of the graft member


16


from D


1


to D


2


may also be associated with a plastic deformation.




In one embodiment, the articulating arm members may have a low strain configuration that is associated with the collapsed diameter D


1


. In this embodiment, a compressive load is applied to the articulating arm members


18


when either the guidewire


12


or the catheter body member


14


are moved relative to one another thus causing the articulating arm members to buckle outward and enlarging the proximal end


20


of the graft member


16


to D


2


. The articulating arm members


18


and the graft member


16


assume their collapsed configurations upon removal of the compressive load.




In a further embodiment, the articulating arm members


18


may alternatively have a low strain configuration that is associated with the deployed diameter D


2


. In this embodiment, a tensile load must be maintained in the articulating arm members


18


to keep the articulating arm members


18


and the graft member


16


in the collapsed state D


1


. The articulating arm members


18


and the graft member


16


assume their respective deployed configurations upon removal of the tensile load when either the guidewire


12


or the catheter body member


14


are moved relative to one another. The articulating arm members


18


and the graft member


16


reassume their respective collapsed configuration upon reapplication of the tensile load.




In accordance with a preferred embodiment of the present invention, the graft member


16


is fabricated of a superelastic material which is capable of undergoing two-way transition between an austenite phase to a martensite phase as a result of stress and strain applied through the plurality of articulating arm members


18


to diametrically expand and diametrically collapse the graft member


16


.




Preferably, the distal end


21


of the graft member


16


does not undergo any or any appreciable diametric expansion. However, during diametric expansion of the proximal end


20


of the graft member


16


, the graft member


16


assumes a generally frustroconical shape with a taper of the graft member from its proximal end


20


to its distal end


21


.




Because the graft member


16


undergoes differential diametric expansion along its longitudinal axis, the relative degree of expansion of the plurality of openings


30


along the longitudinal axis of the graft member


16


will also vary. The openings


30


toward the proximal end


20


of the graft member


16


will exhibit a greater degree of expansion than will the openings


30


toward the distal end


21


of the graft member


16


. Thus, in its expanded state, the graft member


16


will have a differential open surface area along its longitudinal axis. With this arrangement, the larger diametric region of the graft member


16


has larger openings in closer proximity to the walls of the blood vessel and the relatively slower region of the fluid flow through the blood vessel, where larger, slower moving emboli and particulate matter is more likely to be located in the blood flow. Conversely, the distal region of the graft member


16


has smaller openings in closer positional proximity to a central luminal region of the blood flow, where there is a relatively faster rate of fluid flow and where the smaller, faster moving, emboli and particulate matter is more likely to be found in the blood flow. The EPD


10


, therefore, exposes the blood flow distal an interventional device to a gradient of openings in the graft member


16


which more closely approximates the blood flow velocities relative to the transverse cross-sectional area of the vasculature and positions dimensionally sized openings in a more correct orientation relative to the blood flow velocities than with conventional devices. The expansive feature of the EPD


10


also allows for improved apposition of the graft member


16


to the vessel wall regardless of the expansion ratio D


2


/D


1


, particularly since the graft member


16


is not subject to folding, as in the prior art.




Additionally, relative movement of either the guidewire


12


or the catheter body member


14


, depending on the embodiment of the present invention, collapses the graft member


16


with a concomitant reduction in size of the openings


30


. As depicted in

FIG. 4

, any emboli or particulate matter


5


is captured and sequestered within the lumen of the graft member


16


. During contraction of the graft member


16


, the size of the openings


30


also reduces, which minimizes undesired extrusion of the captured emboli and particulate matter through the openings


30


and ejection of the extrudate into the blood flow of the patient. Thus, a greater quantum of emboli and other particulate matter is both captured and withdrawn from the body with the present invention than is found with conventional embolic protection devices.





FIGS. 5-8

illustrate an embolic protection device


50


in accordance with a further embodiment of the invention. Like the EPD


10


, the EPD


50


also generally comprises a graft member


52


fabricated of metal, polymeric or pseudometallic materials as described above, a guidewire


54


, and a catheter body member


58


. The graft member


52


is preferably fabricated of a mesh material having a woven web


51


and a plurality of interstitial spaces


55


within the woven web


51


. The graft member


52


is coaxially and concentrically positioned about the guidewire


54


. The catheter body member


58


is also coaxially and concentrically positioned about the guidewire


54


. The catheter body member


58


is interconnected with a proximal end


53


of the graft member


52


by a plurality of arms


60


. Each of the plurality of arms


60


is preferably oriented parallel to the longitudinal axis of the EPD


50


when the EPD is in its undeployed state. When the EPD


50


is in its undeployed state, a distal end of the catheter body member may be proximally positioned relative to the proximal end of the graft member


52


, or it may be concentrically positioned between the graft member


52


and the guidewire


54


. A distal end of the graft member


52


is coupled either to the guidewire


54


or to an atraumatic tip


56


.




Relative movement of either the guidewire


54


and atraumatic tip


56


in a retrograde direction or of the catheter body


58


in an antegrade direction, exerts an applied pressure to the plurality of arms


60


causing flexion of the plurality of arms


60


from the longitudinal axis and into a radial orientation, and the arms exert a radially expansive force to the proximal end


53


of the graft member


52


.




In another embodiment, relative movement of either the guidewire


54


and atraumatic tip


56


in a retrograde direction or of the catheter body


58


in an antegrade direction reduces or removes a tensile stress present in the articulating arm members


60


such as to allow the articulating arm members


60


to assume a lower strain deployed configuration.




As depicted in

FIGS. 6 and 8

, the proximal end


53


of graft member


52


diametrically enlarges and urges the graft member


52


from a tubular shape to a frustroconical shape. Again, like EPD


10


, the interstitial openings


55


in EPD


50


also enlarge proportionate to the degree of diametric enlargement of the corresponding transverse cross-sectional area of the graft


52


. Again, when the EPD


50


is in its deployed state, there is a differential open surface area along the longitudinal axis of the graft member


52


that presents a gradient in open surface area. Similar to EPD


10


, when the graft member


52


is collapsed, the enlarged interstitial openings


55


in web


51


reduce in size to capture emboli and particulate matter within the graft member


52


while minimizing extrudate through the openings


55


during collapse.




Like the EPD


10


, the graft member


52


is preferably fabricated of a superelastic material and is capable of undergoing two-way transformation from the austenite to the martensite phase under the influence of an applied stress and strain from relative movement of the guidewire


54


and catheter body


58


through the plurality of arms


60


. Each of the plurality of arms


60


may also be fabricated of superelastic material and have both an austenitic phase shape and a martensitic phase shape corresponding to the transformation shapes of the graft member


52


. By fabricating both the graft


52


and the plurality of arms


60


of superelastic materials, the relative movement of the guidewire


54


and the catheter body member


58


exerts an applied stress-strain to the arms


60


and graft member


52


sufficient to cause phase transition and, therefore, transforms the geometries of the arms


60


and graft member


52


. Alternatively, the graft member


52


and the plurality of arms


60


may be fabricated of like plastically deformable or self-expanding materials, such as stainless steel, or may be fabricated of different materials, with the arms


60


being fabricated of a self-expanding elastically, plastically or superelastically deformable material and the graft member


54


being fabricated of an elastic or superelastic material. Thus, the arms


60


and the graft member


54


may be fabricated of like or different materials that exhibit like or distinct material properties.





FIGS. 9A and 9B

illustrate an embolic protection device


70


in accordance with other embodiments of the invention. The EPD


70


is similar in construction to the EPD


10


, with the exception that the articulating arm members


18


are replaced by articulating arm members


72


that are integrally formed in a distal portion of the catheter body member


14


. The articulating arm members


72


are formed by cutting slits


74


into a distal tubular portion of the catheter body member


14


. As shown, the slits extend longitudinally along the catheter body member


14


. Alternatively, the slits may spiral around a portion of the catheter body member


14


. The graft member


16


is placed concentrically around a distal portion of the catheter body member


14


, such that it is over the arm members


72


and slits


74


. The catheter body member


14


and the graft member


16


are connected (e.g., by welding) to the guide wire


12


at the distal end of the catheter body member


14


and graft member


16


by connection


76


. In the embodiment shown in

FIG. 9A

, the articulating arm members


72


are shape set in a closed configuration. To deploy the graft member


16


, the catheter body member


14


is moved distally while the guide wire


12


is not moved, thereby causing articulating arm members


72


to buckle outward and deploy the graft member


16


. In the embodiment shown in

FIG. 9B

, the articulating arm members


72


may also have a low strain configuration that is associated with the deployed diameter D


2


of the graft member


16


. The catheter body member


14


is pulled proximally with respect to the guide wire


12


to maintain tension with the guide wire


12


such that the articulating arm members


72


are straightened and the graft member


16


remains in an undeployed (“captured”) state. Relieving the tension between the guide wire


12


and the catheter body member


14


by moving the catheter body member


14


distally with respect to the guide wire


12


, the arm members


72


return to an open shape such that graft member


16


is deployed.





FIGS. 10A and 10B

illustrate an embolic protection device


80


in accordance with another embodiment of the invention. The EPD


80


is similar in construction to the EPD


10


, with the exception that the articulating arm members


18


are replaced by articulating arm members


82


that are integrally formed in a distal portion of the guidewire


12


. The articulating arm members


82


are formed by cutting slits


84


into a distal tubular portion of the guidewire


12


, when at least a portion of the guide wire


12


is of tubular shape. As shown, the slits extend longitudinally along the guide wire


12


. Alternatively, the slits may spiral around a portion of the guide wire


12


. The graft member


16


is placed concentrically around a distal portion of the guide wire


12


, such that it is over the arm members


82


and slits


84


and can be connected (e.g., by welding) to the guide wire


12


at the distal end of the graft member by connection


86


. In this embodiment, the articulating arm members


82


may also have a low strain configuration that is associated with the deployed diameter D


2


and the catheter body member


14


acts as a capture sheath such that in the captured state, the catheter body member


14


prevents the articulating arm members


82


from expanding the graft member


16


. With this arrangement, the catheter body member


14


is retracted for deployment of the articulating arm members


82


which in turn force the graft member into the deployed or expanded condition, as shown in FIG.


10


B. Likewise, the catheter body


14


can be moved in the opposite direction to force the articulating arm members


82


, and thus the graft member


16


, to their collapsed or undeployed condition as shown in FIG.


10


A. It will be understood that the articulating arm members can alternatively be in the form of wire like attachments connected to the distal end of the guidewire


12


.




Thus, it will be appreciated by those of ordinary skill in the art that the inventive embolic protection device is suitable for use alone as an in-dwelling device or for use in conjunction with a balloon catheter, for capturing emboli and/or other particulate matter within the bloodstream of a patient. Moreover, the embodiments of the inventive embolic protection device employ a porous graft that is urged, either under the influence of superelastic phase transformation, plastic deformation or self-expanding properties, into a frustroconical shape having a proximal end that is diametrically enlarged to capture emboli and other particulate matter, then is collapsible to capture the matter within the graft with a minimal degree of extrusion of particulate matter through the pores of the graft. The porous openings in the graft are differentially expansible proportionate to the degree of expansion of a corresponding transverse cross-sectional region of the graft member, where the porous openings differentially expand and contract during deployment and collapse of the graft to capture the particulate matter therein.




When the inventive embolic protection device is withdrawn from the body, the emboli and particulate matter within the graft member are captured and sequestered. In conventional devices that are characterized by more static open regions, there is a tendency for the emboli and particulate matter to extrude through the open regions when the embolic device is collapsed. Because conventional devices employ more constant area of open region, a greater quantum of emboli and particulate matter will be ejected by extrusion through the open regions. However, with the present invention, the dimension of the open regions changes during diametric expansion and during diametric contraction. Because there is a reduction in the dimension of the open regions during diametric contraction, the present invention is substantially less susceptible to embolic extrusion through the graft member during collapse of the graft member. Thus, a greater quantum of emboli and other particulate matter is both captured and withdrawn from the body with the present invention than is found with conventional embolic protection devices.




EXAMPLE 1




In accordance with the preferred embodiment of fabricating the inventive microporous metallic implantable device in which the device is fabricated from vacuum deposited nitinol tube, a cylindrical deoxygenated copper substrate is provided. The substrate is mechanically polished and/or electropolished to provide a substantially uniform surface topography for accommodating metal deposition thereupon. A cylindrical hollow cathode magnetron sputtering deposition device was employed, in which the cathode was on the outside and the substrate was positioned along the longitudinal axis of the cathode. A cylindrical target consisting either of a nickel-titanium alloy having an atomic ratio of nickel to titanium of about 50-50% and which can be adjusted by spot welding nickel or titanium wires to the target, or a nickel cylinder having a plurality of titanium strips spot welded to the inner surface of the nickel cylinder, or a titanium cylinder having a plurality of nickel strips spot welded to the inner surface of the titanium cylinder is provided. It is known in the sputter deposition acts to cool a target within the deposition chamber by maintaining a thermal contact between the target and a cooling jacket within the cathode. In accordance with the present invention, it has been found useful to reduce the thermal cooling by thermally insulating the target from the cooling jacket within the cathode while still providing electrical contact to it. By insulating the target from the cooling jacket, the target is allowed to become hot within the reaction chamber. Two methods of thermally isolating the cylindrical target from the cooling jacket of the cathode were employed. First, a plurality of wires having a diameter of 0.0381 mm were spot welded around the outer circumference of the target to provide an equivalent spacing between the target and the cathode cooling jacket. Second, a tubular ceramic insulating sleeve was interposed between the outer circumference of the target and the cathode cooling jacket. Further, because the Ni—Ti sputtering yields can be dependant on target temperature, methods which allow the target to become uniformly hot are preferred.




The deposition chamber was evacuated to a pressure less than or about 2-5×10


−7


Torr and pre-cleaning of the substrate is conducted under vacuum. During the deposition, substrate temperature is preferably maintained within the range of 300 and 700 degrees Centigrade. It is preferable to apply a negative bias voltage between 0 and −1000 volts to the substrate, and preferably between −50 and −150 volts, which is sufficient to cause energetic species arriving at the surface of the substrate. During deposition, the gas pressure is maintained between 0.1 and 40 mTorr but preferably between 1 and 20 mTorr. Sputtering preferably occurs in the presence of an Argon atmosphere. The argon gas must be of high purity and special pumps may be employed to reduce oxygen partial pressure. Deposition times will vary depending upon the desired thickness of the deposited tubular film. After deposition, the plurality of microperforations are formed in the tube by removing regions of the deposited film by etching, such as chemical etching, ablation, such as by excimer laser or by electric discharge machining (EDM), or the like. After the plurality of microperforations are formed, the formed microporous film is removed from the copper substrate by exposing the substrate and film to a nitric acid bath for a period of time sufficient to remove or dissolve the copper substrate.




While the invention has been taught with specific reference to the above-described embodiments, those skilled in the art will recognize that changes can be made in form and detail without departing from the spirit and the scope of the invention. Thus, the described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.



Claims
  • 1. An embolic protection device, comprising:a first elongate member having a lumen; a second elongate member extending through the lumen and being movable with respect to the first elongate member; and a graft member constructed from a metal having a characteristic that is at least one of a superelastic material, a plastically deformable material and an elastic material, the graft member having a proximal end portion connected to the first elongate member and a distal end portion connected to the second elongate member, and a plurality of openings extending through the graft member along a length thereof; the graft member being expandable from an undeployed generally tubular state to a deployed generally frustroconical state upon relative movement between the first and second elongate members in a first direction, the openings decreasing in size from the proximal end toward the distal end when the graft member is in the deployed state to thereby capture and retain emboli and other particulate matter of different sizes.
  • 2. An embolic protection device according to claim 1, wherein the openings are substantially uniform in size when the graft member is in the undeployed state.
  • 3. An embolic protection device according to claim 1, and further comprising a plurality of arm members extending between the first elongate member and the proximal end of the graft member, such that relative movement of the first and second elongate members in the first direction causes the arm members to move from a generally axial orientation to a generally radial orientation to thereby radially expand the proximal end of the graft member.
  • 4. An embolic protection device according to claim 3, wherein the distal end of the graft member is substantially restrained against radial expansion such that the diameter of the graft member decreases from the proximal end toward the distal end when the graft member is in the deployed state.
  • 5. An embolic protection device according to claim 4, wherein the size of each opening is proportional to the diameter of the graft member at which each opening is located.
  • 6. An embolic protection device according to claim 5, wherein relative movement of the first and second elongate members in a second direction opposite the first direction causes the graft member to return to the undeployed state, thereby reducing the size of the openings at least at the proximal end, such that the emboli and other particulate matter can be entrapped within the graft member.
  • 7. An embolic protection device according to claim 6, wherein the openings are substantially uniform in size when the graft member is in the undeployed state.
  • 8. An embolic protection device according to claim 1, wherein the distal end of the graft member is substantially restrained against radial expansion such that the graft member decreases in diameter from the proximal end toward the distal end when the graft member is in the deployed state.
  • 9. An embolic protection device according to claim 8, wherein the size of each opening is proportional to the diameter of the graft member at which each opening is located.
  • 10. An embolic protection device according to claim 1, wherein relative movement of the first and second elongate members in a second direction opposite the first direction causes the graft member to return to the undeployed state, thereby reducing the size of the openings at least at the proximal end, such that the emboli and other particulate matter can be entrapped within the graft member.
  • 11. An embolic protection device according to claim 1, wherein the graft member is constructed of a thin film metal.
  • 12. An embolic protection device according to claim 11, wherein the thin film metal comprises a nickel titanium alloy.
  • 13. An embolic protection device according to claim 1, wherein the graft member is constructed of braided wire.
  • 14. An embolic protection device according to claim 1, wherein the first elongate member is a catheter.
  • 15. An embolic protection device according to claim 14, wherein the second elongate member is a guide wire.
  • 16. An embolic protection device according to claim 15, wherein the guide wire has an atraumatic tip at a distal end thereof.
  • 17. An embolic protection device according to claim 1, wherein the second elongate member has a tubular distal portion, and further comprising a plurality of arm members integrally formed in the tubular portion in proximity with the proximal end of the graft member, the plurality of arm members being biased toward an expanded arm position and normally restrained in a retracted arm position by the first elongate member, such that relative movement of the first and second elongate members in the first direction causes the arm members to move from the retracted arm position toward the expanded arm position to thereby radially expand the proximal end of the graft member.
  • 18. An embolic protection device comprising:a catheter body having a central longitudinal lumen; a guidewire having an atraumatic tip positioned at a distal end thereof, the guidewire being coaxially positioned within the central longitudinal lumen of the catheter body; and a graft member movable between an undeployed state and a deployed state, the graft member being of a generally tubular shape in the undeployed state and of a generally frustroconical shape in the deployed state, the graft member comprising a plurality of openings extending along a longitudinal axis thereof, the openings decreasing in size from the proximal end toward the distal end when the graft member is in the deployed state, with a distal end of the graft member being connected to one of the guidewire and the atraumatic tip, the graft member being movable between the undeployed and deployed states upon relative movement between the catheter body and the guide wire, the graft member being constructed of a metal having a characteristic that is at least one of a superelastic material, a plastically deformable material and an elastic material such that each opening expands and reduces in size in proportion to an amount of radial expansion and reduction, respectively, of a corresponding transverse cross sectional region of the graft member with which the opening is associated, to thereby capture emboli and other particulate matter when the graft member is in the deployed state and minimize extrusion of the captured material through the openings in the graft member when the graft member is in the undeployed state.
  • 19. An embolic protection device according to claim 18, wherein the openings are substantially uniform in size when the graft member is in the undeployed state.
  • 20. An embolic protection device according to claim 18, wherein the distal end of the graft member is substantially restrained against radial expansion such that the graft member decreases in diameter from the proximal end toward the distal end when the graft member is in the deployed state.
  • 21. An embolic protection device according to claim 18, wherein the graft member is constructed of a thin film metal.
  • 22. An embolic protection device according to claim 21, wherein the thin film metal comprises a nickel titanium alloy.
  • 23. An embolic protection device according to claim 18, wherein the graft member is constructed of braided wire.
  • 24. An embolic protection device according to claim 18, wherein the guidewire has a tubular portion, and further comprising a plurality of arm members integrally formed in the tubular distal portion in proximity with the graft member, the tubular arm members being biased toward an expanded arm position and normally restrained in a retracted arm position by the catheter body, such that relative movement of the guidewire and catheter body direction causes the arm members to move from the retracted arm position toward the expanded arm position to thereby radially expand the proximal end of the graft member.
  • 25. An embolic protection device according to claim 24, wherein the arm members are constructed of braided wire.
  • 26. An embolic protection device according to claim 18, wherein when the graft member expands during movement from the undeployed state to the deployed state, both the geometry of the openings vary compared to the undeployed state and the size of the openings expand.
  • 27. An embolic protection device according to claim 18, wherein the openings are in the form of longitudinal slots in a thin film metal when the graft member is in the undeployed state.
  • 28. An embolic protection device according to claim 27, wherein when the graft member expands during movement from the undeployed state to the deployed state, both the geometry of the openings vary compared to the undeployed state and the size of the openings expand.
  • 29. An embolic protection device according to claim 1, wherein when the graft member expands during movement from the undeployed state to the deployed state, both the geometry of the openings vary compared to the undeployed state and the size of the openings expand.
  • 30. An embolic protection device according to claim 1, wherein the openings are longitudinal slots formed in a thin film metal when the graft member is in the undeployed state.
  • 31. An embolic protection device according to claim 30, wherein when the graft member expands during movement from the undeployed state to the deployed state, both the geometry of the openings vary compared to the undeployed state and the size of the openings expand.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Continuation-in-Part of U.S. patent application Ser. No. 09/532,164 filed on Mar. 20, 2000, now abandoned the disclosure of which is hereby incorporated by reference. This application also claims the benefit of U.S. Provisional Application No. 60/313,294 filed on Aug. 17, 2001.

US Referenced Citations (115)
Number Name Date Kind
4510182 Cornils et al. Apr 1985 A
4751099 Niino et al. Jun 1988 A
4846834 von Recum et al. Jul 1989 A
5049251 Inone Sep 1991 A
5061914 Busch et al. Oct 1991 A
5084151 Vallana Jan 1992 A
5133845 Vallana et al. Jul 1992 A
5158750 Finicie Oct 1992 A
5242710 Claar et al. Sep 1993 A
5277933 Claar et al. Jan 1994 A
5329514 Eguchi et al. Jul 1994 A
5370684 Vallana et al. Dec 1994 A
5376463 Bak et al. Dec 1994 A
5387247 Vallana et al. Feb 1995 A
5421955 Lau et al. Jun 1995 A
5477864 Davidson Dec 1995 A
5514154 Lau et al. May 1996 A
5540820 Terakado et al. Jul 1996 A
5545210 Hess et al. Aug 1996 A
5569295 Lam Oct 1996 A
5593442 Klein Jan 1997 A
5603721 Lau et al. Feb 1997 A
5605714 Dearnaley et al. Feb 1997 A
5607445 Summers Mar 1997 A
5607463 Schwartz et al. Mar 1997 A
5609629 Fearnot et al. Mar 1997 A
5628788 Pinchuk May 1997 A
5630840 Mayer May 1997 A
5647858 Davidson Jul 1997 A
5649951 Davidson Jul 1997 A
5656036 Palmaz Aug 1997 A
5683453 Palmaz Nov 1997 A
5685961 Pourrezaei et al. Nov 1997 A
5690670 Davidson Nov 1997 A
5723219 Kolluri Mar 1998 A
5725573 Dearnaley et al. Mar 1998 A
5728158 Lau et al. Mar 1998 A
5735896 Amon et al. Apr 1998 A
5744515 Clapper Apr 1998 A
5765418 Rosenberg Jun 1998 A
5769816 Barbut et al. Jun 1998 A
5772864 Moller et al. Jun 1998 A
5776161 Globerman Jul 1998 A
5780807 Saunders Jul 1998 A
5782908 Cahalan et al. Jul 1998 A
5782910 Davidson Jul 1998 A
5788558 Klein Aug 1998 A
5798042 Chu et al. Aug 1998 A
5811151 Hendriks et al. Sep 1998 A
5824045 Alt Oct 1998 A
5824049 Ragheb Oct 1998 A
5824056 Rosenberg Oct 1998 A
5840009 Fischell et al. Nov 1998 A
5843117 Alt et al. Dec 1998 A
5843289 Lee et al. Dec 1998 A
5849206 Amon et al. Dec 1998 A
5855600 Alt Jan 1999 A
5855802 Acciai et al. Jan 1999 A
5855955 Claar et al. Jan 1999 A
5858556 Eckert et al. Jan 1999 A
5866113 Hendriks et al. Feb 1999 A
5868782 Frantzen Feb 1999 A
5873904 Ragheb et al. Feb 1999 A
5876432 Lau et al. Mar 1999 A
5879370 Fischell et al. Mar 1999 A
5891507 Jayaraman Apr 1999 A
5895406 Gray et al. Apr 1999 A
5899935 Ding May 1999 A
5907893 Zadno-Azizi Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5913896 Boyle et al. Jun 1999 A
5919225 Lau et al. Jul 1999 A
5925063 Khosravi Jul 1999 A
5928260 Chin et al. Jul 1999 A
5932299 Katoot Aug 1999 A
5938682 Hojeibane et al. Aug 1999 A
5938697 Killion et al. Aug 1999 A
5941869 Patterson et al. Aug 1999 A
5945153 Dearnaley Aug 1999 A
5951881 Rogers et al. Sep 1999 A
5955588 Tsang et al. Sep 1999 A
5962138 Kolluri et al. Oct 1999 A
5968091 Pinchuk et al. Oct 1999 A
5972018 Israel et al. Oct 1999 A
5972027 Johnson Oct 1999 A
5984905 Dearnaley et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
6013855 McPherson et al. Jan 2000 A
6015429 Lau et al. Jan 2000 A
6019784 Hines Feb 2000 A
6022370 Tower Feb 2000 A
6027520 Tsugita et al. Feb 2000 A
6027526 Limon et al. Feb 2000 A
6033433 Ehr et al. Mar 2000 A
6042597 Kveen et al. Mar 2000 A
6056776 Lau et al. May 2000 A
6059808 Boussignac May 2000 A
6066167 Lau et al. May 2000 A
6066168 Lau et al. May 2000 A
6066169 McGuinness May 2000 A
6071305 Brown et al. Jun 2000 A
6086773 Dufresne et al. Jul 2000 A
6096175 Roth Aug 2000 A
6106642 DiCarlo et al. Aug 2000 A
6142987 Tsugita Nov 2000 A
6152946 Broome et al. Nov 2000 A
6165200 Tsugita et al. Dec 2000 A
6168604 Cano Jan 2001 B1
6171328 Addis Jan 2001 B1
6277139 Levinson et al. Aug 2001 B1
6312463 Rourke et al. Nov 2001 B1
6605111 Bose et al. Aug 2003 B2
20010012951 Bates et al. Aug 2001 A1
20010039449 Johnson et al. Nov 2001 A1
Foreign Referenced Citations (21)
Number Date Country
1452370 Mar 1969 DE
0400947 Dec 1990 EP
0442303 Aug 1991 EP
51055724 May 1976 JP
60162761 Aug 1985 JP
61-88135 Jul 1994 JP
11267462 Oct 1999 JP
WO 9707257 Feb 1997 WO
WO 9744692 Nov 1997 WO
WO 9813537 Apr 1998 WO
WO 9834673 Aug 1998 WO
WO 9845506 Oct 1998 WO
WO 9850103 Nov 1998 WO
WO 9923977 May 1999 WO
WO 0135858 May 2001 WO
WO 0149208 Jul 2001 WO
WO 0149215 Jul 2001 WO
WO 0152768 Jul 2001 WO
WO 0153559 Jul 2001 WO
WO 0155473 Aug 2001 WO
WO 0156502 Aug 2001 WO
Non-Patent Literature Citations (55)
Entry
M. Kohl et al., “Thin film shape memory microvalves with adjustable operation temperature,” Sensors and Actuators, 83(1-3):214-219 (May 2000).
Gordon et al., “Liquid Sources for Chemical Vapor Deposition of Group 6 Metals and Metal Nitrides,” www.techtransfer.harvard.edu/cgi-bin/TALSearch.cgi?full_report=1&case=3, Case No. 1709.
Curtis et al., “Reactions of Biological Cells to Nanostructures,” AVS 46th International Symposium, Paper BI-WeM2 (Oct. 27, 1999).
“Fabrication of Small-Scale Coils and Bands as Photomasks on Optical Fibers for Generation of In-Fiber Gratings, Electromagnets as Micro-NMR Coils, Microtransformers, and Intra-Vascular Stents,” www.techtransfer.harvard.edu/cgi-bin/TALSearch.cgi?full_report=1&case=72, Case No. 1263.
“Biocompatibility of Cardiac Cells on Silane-Modified Surfaces,” AVS 46th International Symposium, Paper BI-WeM5 (Oct. 27, 1999).
“Biofunctionalization of Surfaces with Peptide Amphilphiles,” AVS 46th International Symposium, Paper No. BI-WeM7 (Oct. 27, 1999).
“Plasma Copolymer Surfaces for Cell Culture,” AVS 46th International Symposium, Paper No. BI-WeM9 (Oct. 27, 1999).
“Plasma Co-polymer Surfaces for the Conrolled Adsorption of Common Proteins,” AVS 46th International Symposium, Paper No. BI-FrM2 (Oct. 29, 1999).
“Biofilm—Titanium Chemistry of Adhesion Using X-ray Photoelectron Spectroscopy,” AVS 46th International Symposium, Paper No. BI-FrM10 (Date Missing).
“Nanoscale Patterning of Gold for Attachment of Supported Lipid Bilayers,” AVS 46th International Symposium, Paper No. BI-FrM10 (Date Missing).
“Focused Ion Beam NonaFabrication,” http://www.glue.umd.edu/˜astan/avs04.htm.
“Amorphous Carbon and C:N Thin Films,” http://www.glue.umd.edu/˜astan/avs01.htm.
“Multilayer Ceramic/Metallic Coatings by Ion Beam-Assisted, Electron Beam Physical Vapor (EB-PVD) Deposition,” Penn State Applied Research Laboratory, pp. 1-4 (1997).
“Benefits From Diamond-Like Coated Stainless Steel Stents,” http://www.phytis.com/stents0.htm, pp. 1-2.
“Adhesion of Bovine Serus Albumin on Coated DLC (Diamond-Like) and Uncoated (SiO2/TiO2) Sensor Chips,” http://www.phytis.com/stent4.htm, pp. 1-2.
“Flow Cytometric Investigation,” http://www.phytis.com/stent6.htm, pp. 1-3.
“Pre-clinical and Clinical Evaluation,” http://www.phytis.com/stent2.htm, pp. 1-2.
“The New Phytis Stent,” http://www.phytis.com/stent1.htm, pp. 1-2.
“Invulnerability and Resistance of DLC-Coating,” http://www.phytis.com/stent3.htm, pp. 1-3.
“Material in Use and Its Biocompatibility,” http://www.phytis.com/stent5.htm, pp. 1-2.
“Expertise Concerning the Implementation of the Phytis Diamond As Stent Performed at the Institute for Experimental Medicine (IEM),” http://www.phytis.com/stent9.htm. p. 1.
“Phytis L.D.A. Home Page Information,” http://www.phytis.com/content/htm, pp. 1-15.
“Risk Analysis of Stents With a Diamond-Like Coated Surface For Use in Prosthetic Implants,” http://www.phytis.com/risk.htm, pp. 1-6.
“Directions for Use, Diamond AS® Stent,” http://www.phytis.com/direcuse.htm, pp. 1-8.
“Stents: Literature,” http://www.phytis.com/liter.htm, pp. 1-8.
“Vacuum Conditions for Sputtering Thin Film TiNi,” Journal of Vacuum Science and Technology, JVST A Online, pp. 1-2 (Abstract view).
Gisser et al., “Oriented nickel-tetanium shape memory alloy films prepared by annealing during deposition,” Applied Physics Letters, 61(14):1632-1634 (Abstract view) (Date Missing).
K.S. Fancey et al., “Relative importance of bombardment energy and intensity in ion plating,” Journal of Vacuum Science & Technology A: Vacuum, Surfaces and Films, 13(2):428-435 (Abstract view) (Mar. 1995).
“Directions for Use, Diamond AS® Stent,” http://www.phytis.com/direcuse.htm, pp. 1-8.
“Stents: Literature,” http://www.phytis.com/liter.htm, pp. 1-8.
“Vacuum Conditions for Sputtering Thin Film TiNi,” Journal of Vacuum Science and Technology, JVST A Online, pp. 1-2 (Abstract view).
Gisser et al., “Oriented nickel-tetanium shape memory alloy films prepared by annealing during deposition,” Applied Physics Letters, 61(14):1632-1634 (Abstract view) (Date Missing).
K.S. Fancey et al., “Relative importance of bombardment energy and intensity in ion plating,” Journal of Vacuum Science & Technology A: Vacuum, Surfaces and Films, 13(2):428-435 (Abstract view) (Mar. 1995).
F. Goldberg et al., “The Effects of Ion Irradiation on NiTi Shape Memory Alloy Thin Films,” Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies Asilomar Conference Center, Pacific Grove, California, USA, pp. 177-182 (1997).
L. Buchaillot et al., “Constitutive Parts of a Shape Memory Alloy Titanium Nickel Thin Film Catheter,” Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies Asilomar Conference Center, Pacific Grove, California, USA, pp. 183-188 (1997).
Q. Pingshan et al., “The Effect of HCD Technological Factors on the NiTi SMA Film Thickness,” Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies Asilomar Conference Center, Pacific Grove, California, USA, pp. 173-176 (1997).
H. Weixin et al., “The Characteristics of NiTi HCD-Deposited SMA Films,” Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies Asilomar Conference Center, Pacific Grove, California, USA, pp. 167-172 (1997).
A. Ishida et al., “Microstructure of Ti-Rich TiNi Thin Films,” Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies Asilomar Conference Center, Pacific Grove, California, USA, pp. 161-166 (1997).
“Thin Film Shape Memory Alloy Microactuators,” by TiNi Alloy Company (online).
Johnson et al., “Progress in Thin Film Shape Memory Microactuators,” www.sma-mems.com/recent.htm (Overview), pp. 1-5.
W. Ensinger, “The influence of ion irradiation during film growth on the chemical stability of film/substrate systems,” Surface and Coatings Technology, 80:35-48 (1996).
“Sputtering Targets High-Quality Thin Film Materials,” by AMETEK Specialty Metal Products online at www.ametek84.com/fd-sputtering.html, pp. 1-3.
D. Mattox, “A Concise History of Vacuum Coating Technology, Part 2: 1940 to 1975,” www.svc.org/HistoryofVac2.html, pp. 1-15.
M. Mrksich, “Model Surfaces for Studying and Controlling the Adhesion of Cells,” AVS 47th International Symposium, Invited Paper No. BI+EL-TuA1 (Oct. 3, 2000).
D.S. Sutherland et al., “Cell Response to Chemically and Topographically Modified Surfaces,” AVS 47th International Symposium, Paper No. BI+EL-TuA3 (Oct. 3, 2000).
T. Nishikawa et al., “Tissue Formation of Hepatocyles on Micro-Porous Films of Polylactide,” AVS 47th International Symposium, Paper No. BI+EL-TuA10 (Oct. 3, 2000).
R. Daw et al., “Endothelial Cell Organization on Micropatterned Protein Surfaces,” AVS 47th International Symposium, Paper No. BI-WeP21 (Oct. 4, 2000).
J.E. Houston, “The Nanomechanical Properties of Thin Films,” AVS 47th International Symposium, Paper No. TF-TuA1 (Oct. 3, 2000).
E. Kusano et al., “Anomalous Plastic and Elastic Behaviours of Sputter-deposited TiN with 10 or 20 Inserted Thin A1 Layers Evaluated by Nanoindentation,” AVS 47th International Symposium, Paper No. TF-TuA3 (Oct. 3, 2000).
A.D. Johnson et al., “Recent Progress in the Application of Thin Film Shape Memory Alloys,” Proceedings of the First International Conference on Shape Memory and Superelastic Technologies Asilomar Conference Center, Pacific Grove, California, USA, pp. 299-310 (1994).
J.D. Busch et al., “Shape Memory Properties in NiTi Sputter-deposited Film,” J Appl. Phys., 68(12):6224-6226 (Dec. 15, 1990).
J.A. Waker et al., “Thin-film Processing of TiNi Shape Memory Alloy,” Sensors and Actuators, A21-A23, pp. 243-246 (1990).
E. Quandt et al., “Sputter-deposition of TiNi, TiNiPd and TiPd films displaying the two-way shape-memory effect,” Sensors and Actuators, A 53, pp. 434-439 (1996).
V.V. Martynov, “Applications of Shape-Memory Alloy Thin Films,” Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies Asilomar Conference Center, Pacific Grove, California, USA, pp. 1-8 (1997); and.
“Multicomponent Film Deposition by Target Biasing,” IBM Technical Disclosure Bulletin, pp. 1-2 (Jul. 1980).
Provisional Applications (1)
Number Date Country
60/313294 Aug 2001 US
Continuation in Parts (1)
Number Date Country
Parent 09/532164 Mar 2000 US
Child 10/136246 US